Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

NCT01620944 ·Status: TERMINATED ·Phase: PHASE3

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

NCT00120393 ·Status: COMPLETED ·Phase: PHASE3

Atazavanir/Ritonavir-based HAART in Children

NCT01656109 ·Status: COMPLETED ·Phase: PHASE2

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

NCT01605084 ·Status: WITHDRAWN ·Phase: PHASE3

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

NCT00096746 ·Status: COMPLETED

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

NCT00411957 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients

NCT02473328 ·Status: COMPLETED ·Phase: PHASE2

Atazanavir/Ritonavir Maintenance Therapy

NCT00084019 ·Status: COMPLETED ·Phase: NA

Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia

NCT01940198 ·Status: COMPLETED

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

NCT00135447 ·Status: COMPLETED

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

NCT00814879 ·Status: COMPLETED ·Phase: NA

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

NCT00357188 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

NCT01225705 ·Status: WITHDRAWN ·Phase: PHASE4

Pharmacokinetics of Atazanavir in Special Populations

NCT03923231 ·Status: COMPLETED

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

NCT00207142 ·Status: COMPLETED ·Phase: PHASE4

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

NCT00931801 ·Status: COMPLETED ·Phase: PHASE4

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

NCT01332227 ·Status: COMPLETED ·Phase: PHASE4

A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen

NCT00135343 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

NCT01803074 ·Status: COMPLETED ·Phase: PHASE2

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

NCT00389402 ·Status: COMPLETED ·Phase: PHASE4

Atazanavir/r + Lamivudine Dual Therapy

NCT01599364 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

NCT01705574 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics of Low Dose Ritonavir

NCT00622206 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy

NCT00067782 ·Status: COMPLETED ·Phase: PHASE3

Phase IIB Pilot of Atazanavir + Raltegravir

NCT00768989 ·Status: TERMINATED ·Phase: PHASE2